Probiotic
supplementation of infant formulas has been aimed both
at the prevention of rotaviral infections and the treatment
of established disease. Well-controlled clinical studies have
shown that probiotics such asL. rhamnosusGG,L. reuteri,
L. casei Shirota, and B. animalisBb12 can shorten the
duration of acute rotavirus diarrhoea with the strongest
evidence pointing to the effectiveness ofL. rhamnosusGG
andB. animalisBb12